As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.
7 Analysts have issued a ENDRA Life Sciences Inc. forecast:
7 Analysts have issued a ENDRA Life Sciences Inc. forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -8.52 -8.52 |
9%
9%
|
|
| EBIT (Operating Income) EBIT | -8.44 -8.44 |
6%
6%
|
|
| Net Profit | -8.01 -8.01 |
9%
9%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
ENDRA Life Sciences, Inc. develops medical imaging technology. It operates Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.
| Head office | United States |
| CEO | Alexander Tokman |
| Employees | 21 |
| Founded | 2007 |
| Website | www.endrainc.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


